ICD Co. Ltd (040910) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ICD Co. Ltd (040910) has a cash flow conversion efficiency ratio of 0.093x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.87 Billion ≈ $6.01 Million USD) by net assets (₩94.86 Billion ≈ $64.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ICD Co. Ltd (040910) total market value for the company's overall valuation and market capitalisation.
ICD Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how ICD Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ICD Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ICD Co. Ltd ranked by their cash flow conversion efficiency. Explore ICD Co. Ltd cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arch Biopartners Inc
V:ARCH
|
0.128x |
|
IZEA Inc
NASDAQ:IZEA
|
0.024x |
|
Trisula Textile Industries Tbk PT
JK:BELL
|
0.074x |
|
Brand Group (M.G) Ltd
TA:BRND
|
0.030x |
|
Nano Labs Ltd
NASDAQ:NA
|
-0.034x |
|
Aton Resources Inc
V:AAN
|
0.128x |
|
Laserbond Ltd
AU:LBL
|
0.102x |
|
Atec Co. Ltd
KQ:045660
|
-0.056x |
Annual Cash Flow Conversion Efficiency for ICD Co. Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of ICD Co. Ltd from 2013 to 2025. View 040910 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩98.48 Billion ≈ $66.74 Million |
₩8.01 Billion ≈ $5.43 Million |
0.081x | +128.35% |
| 2024-12-31 | ₩96.98 Billion ≈ $65.72 Million |
₩-27.81 Billion ≈ $-18.85 Million |
-0.287x | -2389.05% |
| 2023-12-31 | ₩127.18 Billion ≈ $86.19 Million |
₩-1.47 Billion ≈ $-993.12K |
-0.012x | +87.65% |
| 2022-12-31 | ₩153.25 Billion ≈ $103.85 Million |
₩-14.29 Billion ≈ $-9.69 Million |
-0.093x | -173.78% |
| 2021-12-31 | ₩167.94 Billion ≈ $113.81 Million |
₩21.23 Billion ≈ $14.39 Million |
0.126x | -54.19% |
| 2020-12-31 | ₩179.47 Billion ≈ $121.63 Million |
₩49.53 Billion ≈ $33.57 Million |
0.276x | +69.34% |
| 2019-12-31 | ₩147.06 Billion ≈ $99.66 Million |
₩23.97 Billion ≈ $16.24 Million |
0.163x | -28.22% |
| 2018-12-31 | ₩131.40 Billion ≈ $89.05 Million |
₩29.83 Billion ≈ $20.22 Million |
0.227x | +356.30% |
| 2017-12-31 | ₩134.14 Billion ≈ $90.91 Million |
₩-11.88 Billion ≈ $-8.05 Million |
-0.089x | -9.61% |
| 2016-12-31 | ₩112.69 Billion ≈ $76.37 Million |
₩-9.11 Billion ≈ $-6.17 Million |
-0.081x | -433.22% |
| 2015-12-31 | ₩90.88 Billion ≈ $61.59 Million |
₩2.20 Billion ≈ $1.49 Million |
0.024x | -92.01% |
| 2013-12-31 | ₩105.42 Billion ≈ $71.44 Million |
₩32.00 Billion ≈ $21.69 Million |
0.304x | -- |
About ICD Co. Ltd
ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, … Read more